Medical Care Technologies Inc. (OTCID:MDCE) Highlights Accelerating Revenue Momentum, AI Commercialization and Expanding Subsidiaries
Fiscal 2025 net income rose 53%, while management expects third-quarter 2026 revenue to exceed each of the preceding four quarters.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Medical Care Technologies (OTCID:MDCE) highlighted revenue growth and its first external AI software agreement, valued at up to $250,000.
Fiscal 2025 revenue reached approximately $1.07 million, up 63% year over year, while net income increased 53% to $230,768. Management expects third-quarter 2026 revenue to exceed each of the preceding four quarters. The commercial relationship with Topps generated six-figure business activity in the initial month of the sales arrangement.
For the remainder of 2026 and into 2027, MDCE plans to prioritize revenue-producing opportunities, enterprise software commercialization and expanded subsidiary operations. Future financing and capital-structure decisions will depend on operational requirements, market conditions, available alternatives and applicable legal and contractual requirements.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Major pointFirst external AI software agreement is valued at up to $250,000. 77% of market cap
- Moderate pointFiscal 2025 revenue grew 63% year over year to approximately $1.07 million.
- Moderate pointFiscal 2025 net income increased 53% to $230,768.
- Moderate point. Forward-looking: it has not happened yet and may not happen.Third-quarter 2026 revenue is expected to exceed each of the preceding four quarters.
- Moderate pointTopps sales arrangement generated six-figure business activity within its initial month.
- Minor point. Forward-looking: it has not happened yet and may not happen.MDCE plans enterprise software commercialization and expanded subsidiary operations for the remainder of 2026 and into 2027.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MESA, AZ / ACCESS Newswire / October 28, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) ("MDCE" or the "Company"), a diversified holding company operating across artificial intelligence, technology, sports collectibles, and digital commerce, today highlighted its accelerating commercialization initiatives, strengthening financial foundation, and renewed commitment to building sustainable long-term shareholder value through continued monetization.
Financial Momentum and Expanding Revenue Opportunities
MDCE continues to build upon significant improvements in its financial performance. For fiscal 2025, the Company reported approximately
Management has previously indicated that third-quarter 2026 revenue is expected to exceed each of the preceding four quarters, positioning the Company to report its strongest quarterly revenue performance in the past year. Additional financial details are expected in its upcoming results.
Following substantial investments in technology development, MDCE has begun transitioning its AI initiatives toward revenue-generating commercial applications. The Company's recently announced first external AI software agreement, valued at up to
MDCE continues advancing its diversified technology portfolio, including Strand Scan Pro, an AI-powered commercial and agricultural quality-control platform; MDCE Melanoma Scan and MDCE Wound Care, both in continued development and evaluation; Snapshot Recipes, its AI-powered consumer recipe platform undergoing marketing and monetization initiatives; and Enterprise AI Vision Services, targeting visual inspection, image recognition, and workflow automation opportunities.
Established Subsidiaries Strengthen Commercial Foundation
MDCE's subsidiaries, Infinite Auctions and Real Game Used, continue supporting revenue diversification through auctions, authentication, consignment, and high-value collectibles services.
Infinite Auctions is preparing additional auction events, while the Company's commercial relationship with Topps has generated six-figure business activity within the initial month of the sales arrangement, reinforcing the value of established industry partnerships.
Management believes the combination of established operating subsidiaries and emerging AI commercialization opportunities positions MDCE to pursue additional revenue growth while leveraging investments already made across its businesses.
Strengthening Shareholder Confidence Through Execution
Management recognizes the impact that historical equity issuances and capital-structure changes have had on shareholders and remains focused on strengthening investor confidence through transparent reporting, measurable operating performance, and responsible capital allocation.
As MDCE advances its growth initiatives, future financing and capital-structure decisions will be evaluated based on operational requirements, prevailing market conditions, available alternatives, and applicable legal and contractual requirements. The Company intends to maintain the financial flexibility necessary to support growth while pursuing greater capital efficiency and long-term enterprise value.
Management Commentary
"Our shareholders have supported MDCE through a period of significant investment and development, and we recognize that confidence must be earned through results, not promises," stated Marshall Perkins, Chief Executive Officer of Medical Care Technologies Inc.
"We delivered meaningful revenue and profitability growth in 2025, anticipate our strongest quarterly revenue performance of the past year, and are beginning to convert our AI investments into commercial opportunities. At the same time, our established subsidiaries continue generating business activity and expanding important industry relationships."
"Our priorities are clear: grow revenue, strengthen operational efficiency, commercialize our technologies, and make disciplined capital decisions that support sustainable long-term shareholder value. We understand the importance of demonstrating measurable progress, and that is exactly where our attention is focused."
Positioned for Continued Growth
Looking toward the remainder of 2026 and into 2027, MDCE intends to prioritize revenue-producing opportunities, enterprise software commercialization, recurring and transactional revenue growth, expanded subsidiary operations, and strategic opportunities that complement its existing businesses.
Management believes its diversified operating platform, improving financial performance, and expanding commercial opportunities provide a foundation for the Company's next stage of development.
MDCE's objective is to translate operating momentum into sustainable financial progress and build long-term shareholder confidence through consistent execution.
Additional updates will be provided as material developments occur.
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTCID:MDCE) is a diversified holding company with operations and development initiatives spanning artificial intelligence, enterprise technology, sports collectibles, auctions, and digital commerce. Through its subsidiaries and technology platforms, the Company seeks to expand commercial opportunities, diversify revenue, and create long-term enterprise value.
www.medicalcaretechnologies.com
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the planned amendment of the Regulation A offering. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.
Contact Information:
Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: marshall@medicalcaretechnologies.com
Website: https://www.medicalcaretechnologies.com
SOURCE: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much did Medical Care Technologies revenue and profit grow in fiscal 2025?
Medical Care Technologies reported fiscal 2025 revenue of approximately $1.07 million, up 63% year over year, and net income of $230,768, an increase of 53%.
How much is MDCE's first external AI software agreement worth?
MDCE's first external AI software agreement is valued at up to $250,000. The company has begun transitioning its AI initiatives toward revenue-generating commercial applications following investments in technology development.